Matrix-Bio Inc.

Industry

  • Biotechnology
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
    • Chemistry, Immunoassay
    • Therapeutic Drug Monitoring
See more in Biomedtracker

Latest on Matrix-Bio Inc.

Scrip

Recent Tech Transfer Deals, July 2013

 
• By Deanna Kamienski, Beth Allan, Andrea Mancini, Amanda Micklus, Maureen Riordan, and Theresa Surprenant

IN VITRO DIAGNOSTICS BC Cancer Agency Columbia University Qiagen NV Qiagen licenses biomarker rights from Columbia University and the BC Cancer Agency Assay and molecular diagnostics devel

Medtech Insight

Medical Device Deals Update, June-July 2013

Elsevier’s Strategic Transactions